Business Description
Enzo Biochem Inc
NAICS : 621511
SIC : 8071
ISIN : US2941001024
Description
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.39 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -2.61 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -2.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -26.5 | |||||
| 3-Year EBITDA Growth Rate | 16 | |||||
| 3-Year EPS without NRI Growth Rate | 12.5 | |||||
| 3-Year FCF Growth Rate | -25.8 | |||||
| 3-Year Book Growth Rate | 8.8 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.59 | |||||
| 9-Day RSI | 16.93 | |||||
| 14-Day RSI | 24.68 | |||||
| 6-1 Month Momentum % | -10 | |||||
| 12-1 Month Momentum % | -51.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | |||||
| Quick Ratio | 2.89 | |||||
| Cash Ratio | 2.38 | |||||
| Days Sales Outstanding | 197.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | 10.97 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 112.3 | |||||
| Operating Margin % | -35.44 | |||||
| Net Margin % | 254.3 | |||||
| FCF Margin % | -358.54 | |||||
| ROE % | 59.15 | |||||
| ROA % | 34.22 | |||||
| ROIC % | -10.33 | |||||
| ROC (Joel Greenblatt) % | -19.32 | |||||
| ROCE % | -7.39 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 1.63 | |||||
| Shiller PE Ratio | 109 | |||||
| Price-to-Owner-Earnings | 1.98 | |||||
| PS Ratio | 4.26 | |||||
| PB Ratio | 0.78 | |||||
| Price-to-Tangible-Book | 0.78 | |||||
| EV-to-EBIT | -0.61 | |||||
| EV-to-EBITDA | -1.01 | |||||
| EV-to-Revenue | 0.22 | |||||
| EV-to-FCF | -0.06 | |||||
| Price-to-Net-Current-Asset-Value | 1.05 | |||||
| Price-to-Net-Cash | 1.73 | |||||
| Earnings Yield (Greenblatt) % | -163.93 | |||||
| FCF Yield % | -82.23 | |||||
| Forward Rate of Return (Yacktman) % | 23.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:ENZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enzo Biochem Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 12.806 | ||
| EPS (TTM) ($) | 0.67 | ||
| Beta | 0.78 | ||
| Volatility % | 32.76 | ||
| 14-Day RSI | 24.68 | ||
| 14-Day ATR ($) | 0.052477 | ||
| 20-Day SMA ($) | 1.2045 | ||
| 12-1 Month Momentum % | -51.16 | ||
| 52-Week Range ($) | 1.07 - 2.74 | ||
| Shares Outstanding (Mil) | 51.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enzo Biochem Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enzo Biochem Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enzo Biochem Inc Frequently Asked Questions
What is Enzo Biochem Inc(ENZ)'s stock price today?
The current price of ENZ is $1.09. The 52 week high of ENZ is $2.74 and 52 week low is $1.07.
When is next earnings date of Enzo Biochem Inc(ENZ)?
The next earnings date of Enzo Biochem Inc(ENZ) is 2024-06-14 Est..
Does Enzo Biochem Inc(ENZ) pay dividends? If so, how much?
Enzo Biochem Inc(ENZ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers